Concord Drugs has informed that it enclosed the Certificate from Registrar and Share Transfer Agent (R&T Agent) - Aarthi Consultants under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for Concord Drugs for the quarter ended 30th September, 2025.
The above information is a part of company’s filings submitted to BSE.